CA3089120A1 - Methodes de traitement de l'amyotrophie musculaire - Google Patents

Methodes de traitement de l'amyotrophie musculaire Download PDF

Info

Publication number
CA3089120A1
CA3089120A1 CA3089120A CA3089120A CA3089120A1 CA 3089120 A1 CA3089120 A1 CA 3089120A1 CA 3089120 A CA3089120 A CA 3089120A CA 3089120 A CA3089120 A CA 3089120A CA 3089120 A1 CA3089120 A1 CA 3089120A1
Authority
CA
Canada
Prior art keywords
biological sample
sma
neurofilament
pnf
human subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3089120A
Other languages
English (en)
Inventor
Wildon Farwell
John STAROPOLI
Guolin ZHAO
Alexander Mccampbell
Christopher Cody STEBBINS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen MA Inc
Original Assignee
Biogen MA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen MA Inc filed Critical Biogen MA Inc
Priority claimed from PCT/US2019/015185 external-priority patent/WO2019147960A1/fr
Publication of CA3089120A1 publication Critical patent/CA3089120A1/fr
Pending legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne des biomarqueurs servant, par exemple, au diagnostic et au pronostic de l'amyotrophie spinale (AS) ainsi qu'à l'identification de répondeurs au traitement de l'AS. L'invention concerne également des méthodes de traitement de sujets atteints d'AS.
CA3089120A 2018-01-25 2019-01-25 Methodes de traitement de l'amyotrophie musculaire Pending CA3089120A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862622027P 2018-01-25 2018-01-25
US62/622,027 2018-01-25
US62/684,507 2018-06-13
US62/738,134 2018-09-28
PCT/US2019/015185 WO2019147960A1 (fr) 2018-01-25 2019-01-25 Méthodes de traitement de l'amyotrophie musculaire

Publications (1)

Publication Number Publication Date
CA3089120A1 true CA3089120A1 (fr) 2019-08-01

Family

ID=71946844

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3089120A Pending CA3089120A1 (fr) 2018-01-25 2019-01-25 Methodes de traitement de l'amyotrophie musculaire

Country Status (1)

Country Link
CA (1) CA3089120A1 (fr)

Similar Documents

Publication Publication Date Title
US20230107651A1 (en) Methods of treating spinal muscular atrophy
US11598776B2 (en) Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
US20230393133A1 (en) Blood biomarker that predicts persistent cognitive dysfunction after concussion
JP6803230B2 (ja) アルツハイマー病に関するバイオマーカー及び方法
US10215764B2 (en) Assay reagents for a neurogranin diagnostic kit
US20230194536A1 (en) Markers for the diagnosis and treatment of non-alcoholic steatohepatitis (nash) and advance liver fibrosis
KR20190031072A (ko) 리포칼린-2를 이용한 혈관성 치매의 진단방법
KR101895767B1 (ko) 동맥경화증 진단용 바이오 마커 조성물
KR102547531B1 (ko) 주요 우울 장애 치료 반응성 평가용 바이오마커
CA3089120A1 (fr) Methodes de traitement de l'amyotrophie musculaire
EP3924739A1 (fr) Biomarqueurs de la leucoencéphalopathie multifocale progressive
KR20210119131A (ko) 천식 진단 및 중증도와 치료 반응 예측용 조성물
KR20230153844A (ko) Covid-19 중증도 예측 및 경과 모니터링 방법

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220921

EEER Examination request

Effective date: 20220921